More on PBLS
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $41.32 |
|
|||
| Open | $40.70 | ||||
| 52 Wk High | $0.00 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $41.49 | ||||
| Day Low | $39.31 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 124,169 | ||||
- Form SCHEDULE 13G Parabilis Medicines, Filed by: ARCH Venture Fund XII, L.P.
- Form 10-Q Parabilis Medicines, For: Jun 30
- Form 8-K Parabilis Medicines, For: Aug 13
- Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Form SCHEDULE 13G Parabilis Medicines, Filed by: FMR LLC
- Form 4 Parabilis Medicines, For: Jul 20 Filed by: Shah Rajeev M.
- BofA Securities Starts Parabilis Medicines (PBLS) at Buy
- Leerink Starts Parabilis Medicines (PBLS) at Outperform
- Evercore ISI Starts Parabilis Medicines (PBLS) at Outperform
- Guggenheim Starts Parabilis Medicines (PBLS) at Buy
Entities mentioned with PBLS
- IPO | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Guggenheim | View Related Stories »
- Andrew Berens | View Related Stories »
- 13G | View Related Stories »
- Umer Raffat | View Related Stories »
- Show More...
